220 related articles for article (PubMed ID: 20800343)
1. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.
Burnett MM; Hess CP; Roberts JP; Bass NM; Douglas VC; Josephson SA
Clin Neurol Neurosurg; 2010 Dec; 112(10):886-91. PubMed ID: 20800343
[TBL] [Abstract][Full Text] [Related]
2. Delayed reversible posterior encephalopathy syndrome following chemotherapy with oxaliplatin.
Sharief U; Perry DJ
Clin Colorectal Cancer; 2009 Jul; 8(3):163-5. PubMed ID: 19632931
[TBL] [Abstract][Full Text] [Related]
3. Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome.
Li Y; Gor D; Walicki D; Jenny D; Jones D; Barbour P; Castaldo J
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):873-82. PubMed ID: 21703874
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features of preeclampsia-eclampsia patients with reversible posterior leukoencephalopathy syndrome].
Lu HY; Xie BD; Cheng Y; Niu XM
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):178-81. PubMed ID: 20356553
[TBL] [Abstract][Full Text] [Related]
5. Clinical spectrum of reversible posterior leukoencephalopathy syndrome.
Lee VH; Wijdicks EF; Manno EM; Rabinstein AA
Arch Neurol; 2008 Feb; 65(2):205-10. PubMed ID: 18268188
[TBL] [Abstract][Full Text] [Related]
6. Reversible posterior leukoencephalopathy syndrome: a retrospective study in King Chulalongkorn Memorial Hospital.
Tungkasaereerak C; Phanthumchinda K
J Med Assoc Thai; 2008 Mar; 91(3):427-32. PubMed ID: 18575300
[TBL] [Abstract][Full Text] [Related]
7. [Reversible posterior leukoencephalopathy syndrome in patients with immunosuppressive treatment: report of four cases].
Hernández Ch M; Núñez F A; Mesa L T; Escobar H R; Barriga C F; Huete L I
Rev Med Chil; 2008 Jan; 136(1):93-8. PubMed ID: 18483659
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma.
Mak A; Chan BP; Yeh IB; Ho RC; Boey ML; Feng PH; Koh DR; Ong BK
Rheumatology (Oxford); 2008 Mar; 47(3):256-62. PubMed ID: 18084001
[TBL] [Abstract][Full Text] [Related]
9. Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients.
Akutsu N; Iwashita C; Maruyama M; Ootsuki K; Ito T; Saigo K; Kenmochi T
Transplant Proc; 2008 Sep; 40(7):2416-8. PubMed ID: 18790253
[TBL] [Abstract][Full Text] [Related]
10. Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs.
Marinella MA; Markert RJ
Intern Med J; 2009 Dec; 39(12):826-34. PubMed ID: 19220526
[TBL] [Abstract][Full Text] [Related]
11. Hypertension-induced reversible posterior leukoencephalopathy syndrome causing obstructive hydrocephalus.
Lee SY; Dinesh SK; Thomas J
J Clin Neurosci; 2008 Apr; 15(4):457-9. PubMed ID: 18249121
[TBL] [Abstract][Full Text] [Related]
12. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.
Tam CS; Galanos J; Seymour JF; Pitman AG; Stark RJ; Prince HM
Am J Hematol; 2004 Sep; 77(1):72-6. PubMed ID: 15307110
[TBL] [Abstract][Full Text] [Related]
13. Posterior reversible encephalopathy syndrome after liver transplantation in children: a rare complication related to calcineurin inhibitor effects.
Santos MM; Tannuri AC; Gibelli NE; Ayoub AA; Maksoud-Filho JG; Andrade WC; Velhote MC; Silva MM; Pinho ML; Miyatani HT; Susuki L; Tannuri U
Pediatr Transplant; 2011 Mar; 15(2):157-60. PubMed ID: 21155957
[TBL] [Abstract][Full Text] [Related]
14. [Reversible posterior leukoencephalopathy, severe hypertension, and cocaine abuse].
Rodríguez Gómez E; Rodríguez Gómez FJ; Merino MJ; Robledo A; López Domínguez JM; Fernández Girón F; González Martínez J
Nefrologia; 2001; 21(3):305-8. PubMed ID: 11471311
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of nine children with reversible posterior encephalopathy syndrome.
Incecik F; Hergüner MO; Altunbasak S; Erbey F; Leblebisatan G
Neurol India; 2009; 57(4):475-8. PubMed ID: 19770551
[TBL] [Abstract][Full Text] [Related]
16. Reversible posterior leukoencephalopathy syndrome: a case presentation.
Bell AJ
Neurodiagn J; 2012 Mar; 52(1):20-33. PubMed ID: 22558644
[TBL] [Abstract][Full Text] [Related]
17. Reversible posterior leukoencephalopathy syndrome induced by vinorelbine.
Chen YH; Huang CH
Clin Breast Cancer; 2012 Jun; 12(3):222-5. PubMed ID: 22424944
[TBL] [Abstract][Full Text] [Related]
18. Acute posterior leukoencephalopathy in a patient with nephrotic syndrome.
Utsumi K; Amemiya S; Iizuka M; Iino Y; Katayama Y
Clin Exp Nephrol; 2003 Mar; 7(1):63-6. PubMed ID: 14586746
[TBL] [Abstract][Full Text] [Related]
19. Reversible posterior leukoencephalopathy syndrome in a patient treated with ustekinumab: case report and review of the literature.
Gratton D; Szapary P; Goyal K; Fakharzadeh S; Germain V; Saltiel P
Arch Dermatol; 2011 Oct; 147(10):1197-202. PubMed ID: 21680761
[TBL] [Abstract][Full Text] [Related]
20. Atypical case of reversible posterior leucoencephalopathy syndrome associated with puerperal HELLP syndrome.
Peng WX; Nakaii M; Matsushima T; Asakura H
Arch Gynecol Obstet; 2008 Sep; 278(3):269-71. PubMed ID: 18247035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
